Drug Profile
Human haemoglobin - Northfield Laboratories
Alternative Names: PolyHemeLatest Information Update: 14 May 2009
Price :
$50
*
At a glance
- Originator Northfield Laboratories
- Class Haemoglobins; Plasma expanders
- Mechanism of Action Haemoglobin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypovolaemia